The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York Compounded "semaglutide" is not FDA approved semaglutide.com FDA issued its first warning letter to a dispenser (a medical spa) for violating the Drug Supply Chain Security Act (DSCSA), including failing to source products from authorized trading partners and FDA Is Expected to Lift Restriction on Peptides, Heeding RFK Jr.'s Wishes The New York Times